
A Cost-Effectiveness Analysis of Mosunetuzumab vs Tisagenlecleucel for Treatment of Third- or Higher-Line (3L+) Relapsed ...
Introduction Follicular lymphoma (FL) is a systemic indolent neoplasm of the lymphoid tissue displaying germinal center B cell differentiation. It represents roughly 20–25% of all newly diagnosed non-Hodgkin lymphoma cases in Western countries.1 Even …